background
background
ASND
Ascendis Pharma ADR
$163.57
+4.33
+2.72%
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down
Thursday
May 1, 2025
4:01 PM ET
Ascendis Pharma Reports First Quarter 2025 Financial Results
Thursday
April 24, 2025
4:01 PM ET
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
Wednesday
February 12, 2025
4:01 PM ET
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Wednesday
February 5, 2025
4:01 PM ET
Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025